We are live on ! Find out more
ALT icon

Altimmune
ALT

34 hedge funds and large institutions have $29.6M invested in Altimmune in 2013 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

410% more call options, than puts

Call options by funds: $418K | Put options by funds: $82K

Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
$418K
Puts
$82K
Net Calls
+$336K
Net Calls Change
+$336K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ALT Hedge Fund Activity: Q2 2013 in Review

34 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2013, worth a combined $29.6M.

Buyers outnumbered sellers: 34 funds opened new ALT positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

  • 34 institutional investors held Altimmune (ALT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $29.6M of Altimmune stock for Q2 2013.
  • 34 funds opened new Altimmune positions in Q2 2013 and 0 closed out, a net change of +34 holders.

Based on aggregated 13F filings for Q2 2013.